University Hospitals Birmingham NHS Foundation Trust

Status Drug name NICE TAs Comments
Status: Green Linagliptin tablets
Status: Grey Linzagolix (Yselty®)
Status: Red Liothyronine injection
Status: Amber Liothyronine tablets

ESCA

Status: Green Liquid paraffin (VitA-POS®)

Second line

Status: Green Liquid paraffin (Xailin® night)
Status: Green Liquid paraffin and white soft paraffin 50:50 ointment
Status: Red Liraglutide (Saxenda®) (GLP1s should all be prescribed by brand name)

The use of Liraglutide for this indication is restricted to prescribing in secondary care by a specialist multidisciplinary Tier 3 weight management service with a commercial agreement in place.

Prescribe by brand (Saxenda®) to avoid patients inadvertently receiving a different product licensed for type 2 diabetes.

Status: Green Liraglutide (Victoza®) injection (GLP1s should all be prescribed by brand name)

THIS IS FOR DIABETES ONLY. Prescribe by brand (Victoza®) to avoid patients inadvertently receiving a different product licensed for obesity.

1.8 mg is non-formulary.

Status: Amber Lisdexamfetamine

ESCAs and additional advice in relation to age of patient and CCG

Building healthier lives
Back to top